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A progression in peritubular
capillary flow reduction and
tubulointerstitial fibrosis reflected
by FE Mg predict the decline in
glomerular filtration rate
To the Editor: We read the article of Nielson et al.1 with
great interest. With respect to the crucial mechanism of renal
disease progression, accumulating evidence supports the
integrated roles of a variety of circulating toxins, namely,
oxidative stress, cytokines, sugar, glycation end products,
lipids, and altered shear stress, which induce renal micro-
vascular disease and chronic renal ischemia leading to the
development of tubulointerstitial ﬁrosis.2 In this regard, a
progression in peritubular capillary ﬂow reduction and the
magnitude of tubulointerstitial ﬁbrosis reﬂected by fraction
excretion of magnesium (FE Mg) could predict the decline in
glomerular ﬁltration rate.3,4 The magnitude of tubulointer-
stitial ﬁbrosis is directly reﬂected by the elevated level of FE
Mg.5 Thus, failure of the tubular markers to predict the
decline in glomerular ﬁltration rate in this study implies that
they do not reﬂect the ischemic role, nor the magnitude of
tubulointerstitial ﬁbrosis.
Another interesting issue is the therapeutic resistance to
vasodilators in this rather late diabetic nephropathy (DN),
which correlates well with the general consensus that
vasodilator treatment simply slows the renal disease progres-
sion but is unable to restore renal function. We have recently
demonstrated that such therapeutic resistance is due to
altered vascular homeostasis and an impaired nitric oxide
production observed in late DN, leading to failure in
correcting the ischemic state. In contrast, an adequate
vascular homeostasis is observed in early DN (normoalbu-
minuria)2; therefore, an implementation to treatment at early
DN could enhance renal perfusion, as well as restore renal
function.6–7
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The Authors Reply: We thank Futrakul and Futrakul1 for
their comments on our article2 and for presenting results on
fractional excretion of magnesium (FE Mg). There has been
much focus on the importance of tubular damage and the
predictive role of markers of tubular function, inﬂammation,
and damage in acute and chronic renal disease. We tested
the predictive value on decline in kidney function in a
longitudinal study of recent markers of tubular damage
and inﬂammation—urinary neutrophil gelatinase-associated
lipocalin (u-NGAL), urinary kidney injury molecule-1 (u-KIM1),
and urinary liver-type fatty acid-binding protein (u-LFABP)—
after promising results in cross-sectional settings.3,4 Although
baseline u-KIM1 and u-NGAL were associated with decline
in glomerular ﬁltration rate, they do not add anything to the
predictive value of the traditional risk factors in overt diabetic
nephropathy.
We agree that it would be interesting to ﬁnd new risk
markers that could enhance the prediction of renal prognosis;
however, new markers, such as markers of peritubular ﬂow, as
suggested by the authors, have to be studied in a prospective
setting with precise methods, to evaluate their usefulness as
biomarkers of progression. We look forward to such studies.
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